PTI Wires
PTI
Jan 12, 2022, 06:44 PM | Updated 06:44 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
New Delhi, Jan 12 (PTI) Bharat Biotech on Wednesday said a study has demonstrated that booster dose of Covaxin has neutralising effect on the Omicron and Delta variants of COVID-19.
A study conducted at Emory University demonstrated that subjects who received a booster dose of Covaxin (BBV152) six months after getting a primary two-dose series have witnessed neutralising of the SARS-CoV-2 Omicron and Delta variants, the vaccine major said in a statement.
Earlier studies had demonstrated the neutralising potential of Covaxin against other SARS-CoV-2 variants -- Alpha, Beta, Delta, Zeta and Kappa, it added.
(This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.)